Obstructive sleep apnea: Incidence and impact on hypertension?

Current Cardiology Reports

Volumn 15, Issue 11, 2013, Pages

  Guralnick, Amy S ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Blood pressure; Hypertension; Impact; Incidence; Obstructive sleep apnea; OSA

Indexed keywords

ANTIHYPERTENSIVE AGENT; OXYGEN;

ARTICLE; AUTONOMIC DYSFUNCTION; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR RISK; DAYTIME SOMNOLENCE; DEOXYGENATION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; HEMODYNAMICS; HUMAN; HYPERTENSION; INCIDENCE; INSOMNIA; INTERMITTENT HYPOXIA; MEDICAL DEVICE; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; REOXYGENATION; RESPIRATORY TRACT DISEASE; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING; SLEEP PARAMETERS; SLEEP TIME; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TREATMENT RESPONSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; COMPLICATION; DRUG EFFECTS; FATIGUE; FEMALE; ILLINOIS; MALE; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHICAGO; CONTINUOUS POSITIVE AIRWAY PRESSURE; FATIGUE; FEMALE; HUMANS; HYPERTENSION; INCIDENCE; MALE; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84886905666     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0415-x     Document Type: Article

References (30)

1. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB. Undiagnosed sleep apnea in patients with resistant hypertension. Ann Intern Med. 1985;103:190-5. (Pubitemid 15000567)
2. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J. 1984;108:373-6. (Pubitemid 14061382)
3. Worsnop CJ, Naughton MT, Barter CE, Morgan TO, Anderson AI, Pierce RJ. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med. 1998;157:111-5. (Pubitemid 28071270)
4. Drager LF, Genta RP, Nerbass FB, Gonzagea CC, Krieger EM, Lorenzi-Filho G. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol. 2010;105:1135-9.
5. Young T, Peppard P, Palta M, Hla KM, Finn L, Morgan B, et al. Population-based study of sleep disordered breathing as a risk factor for systemic hypertension. Arch Intern Med. 1997;157:1746-52. (Pubitemid 27327411)
6. Kylintireas I, Craig S, Nethononda R, Kohler M, Francis J, Choudhury R, et al. Atherosclerosis and arterial stiffness in obstructive sleep apnea - a cardiovascular magnetic resonance study. Atherosclerosis. 2012;222:483-9.
7. Bhattacharjee R, Kim J, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D. Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea. Chest. 2012;141:682-91.
8. Usui Y, Takata Y, Inoue Y, Tomiyama H, Kurohane S, Hashimura Y, et al. Severe obstructive sleep apnea impairs left ventricular diastolic function in non-obese men. Sleep Med. 2013;14:155-9.
9. Haentjens P et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnea syndrome. Arch Intern Med. 2007;167:757. (Pubitemid 46658332)
10. Cross MD, Mills NL, Al-Abri M, Riha R, Vennelle M, Mackay TW, et al. Continuous positive airway pressure improves vascular function in obstructive sleep apnoea/hypopnoea syndrome: a randomized controlled trial. Thorax. 2008;63:578-83. (Pubitemid 351969249)
11. Budhiraja R, Quan SF. When is CPAP an antihypertensive in sleep apnea patients? J Clin Sleep Med. 2009;5:108-9.
12. Parati G, Lombardi C. Control of hypertension in non-sleepy patients with obstructive sleep apnea. Am J Respir Crit Care Med. 2010;181:650-2.
13. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;2:397.
14. Dopp JM, Reichmuth KJ, Morgan BJ. Obstructive sleep apnea and hypertension: mechanisms, evaluation, and management. Curr Hypertens Rep. 2007;9:529-34.
15. • Cano-Pumarega I, Dura'n-Cantolla J, Aizpuru F, Miranda-Serrano E, Rubio R, Martinez-Null C, et al. Obstructive sleep apnea and systemic hypertension: longitudinal study in the general population. Am J Respir Crit Care Med. 2011;184:1299-304. This population-based study, which included 1180 subjects, 30-70 years old, randomly sampled from the general population evaluating for incident HTN over 7.5 years follow-up. The risk of HTN increased significantly with more significant sleep disordered breathing, but was not statistically significant once adjusted for age.
16. O'Connor GT, Caffo B, Newman AB, Quan SF, Rapoport DM, Redline S, et al. Prospective study of sleep-disordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med. 2009;179:1159-64.
17. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:1378-84. (Pubitemid 30262394)
18. • Barbé F, Durán-Cantolla J, Capote F, de la Peña M, Chiner E, Masa JF, et al. Spanish Sleep and Breathing Group. Long-term effect of continuous positive airway pressure in hypertensive patients with sleep apnea. Am J Respir Crit Care Med. 2010;181:718-26. CPAP can modify sympathetic activity, endothelial dysfunction, systemic inflammation and abnormal autonomic function, all of which are potential mechanisms for development of HTN in OSA patients.
19. Phillips B, Shafazand S. CPAP and hypertension in nonsleepy patients. J Clin Sleep Med. 2013;9:181-2.
20. • Kasiakogias A, Tsioufis C, Thomopoulos C, Aragiannis D, Alchanatis M, Tousoulis D, et al. Effects of continuous positive airway pressure on blood pressure in hypertensive patients with obstructive sleep apnea: a 3-year follow-up. J Hypertens. 2013;31:352-60. Patients with known OSA and HTN were followed for a mean period of 3.1 years, after achieving office BP less than 140/90 mm Hg. In the non-sleepy, moderate-severe OSA patients, CPAP has no effect on incident HTN nor lower BP levels or a need for less antihypertensive drugs in those patients with known HTN.
21. • Bottini P, Taranto-Montemurro L, Novali M, Bettinzoli M, Roca E, Andreoli C, et al. Effects of CPAP on systemic hypertension in OSAH: a monocentric, observational, cohort study. Respir Med. 2012;106:1329-34. Patients with moderate-severe OSA, treated with at least 4 hours nightly CPAP had a lower risk of increasing treatment for HTN and incident HTN compared with patients with OSA (mild-severe) who were not being treated with CPAP.
22. Gottlieb DJ. Late breaking results of cardiovascular randomized controlled trials in obstructive sleep apnea. HeartBEAT: a Phase 2 RCT of CPAP in high cardiovascular risk patients with OSA. Presented at the Sleep, 2013 Meeting. Baltimore, MD; May 31-June 4, 2013.
23. Aarab G, Lobbezoo F, Hamburger HL, Naeije M. Oral appliance therapy versus nasal continuous positive airway pressure in obstructive sleep apnea: a randomized, placebo-controlled trial. Respiration. 2011;81:411-9.
24. • Andren A, Hedburg P, Walker-Engstrom M. Effects of treatment with oral appliance on 24-hour blood pressure in patients with obstructive sleep apnea and hypertension: a randomized clinical trial. Sleep Breath. 2013;17:705-12. When looking specifically at patients with more significant and moderate OSA there was a statistically significant reduction in 24-hour mean SBP in patients treated with an oral advancement device compared with controls.
25. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet. 1999;354:1435-9. (Pubitemid 29494756)
26. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension. 1996;27:1318-24. (Pubitemid 26165637)
27. Lusardi P, Mugellini A, Preti P, Zoppi A, Derosa G, Fogari R. Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects. Am J Hypertens. 1996;9:503-5. (Pubitemid 26000076)
28. Vgontzas AN, Liao D, Bixler EO, Chrousos GP, Vela-Bueno A. Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep. 2009;32:491-7.
29. • Knutson KL, Van Cauter E, Rathouz PJ, Yan LL, Hulley SB, Liu K, et al. Association between sleep and blood pressure in midlife: the CARDIA sleep study. Arch Intern Med. 2009;169:1055-61. doi: 10.1001/archinternmed.2009.119. In this simple, objectively measured shorter sleep duration by actiugraphy predicted higher levels of HTN. For each hour less of total sleep time there was a 37% increase in the odds of incident hypertension.
30. • Fernandez-Mendoza J, Vgontzas AN, Liao D, Shaffer ML, Vela-Bueno A, Basta M, et al. Insomnia with objective short sleep duration and incident hypertension: the Penn State Cohort. Hypertension. 2012;60:929-35. The Penn State Cohort was a population based study where all subjects underwent a 1 night in-lab PSG. The risk of incident HTN was increased in subjects with both objective and subjective measurements of chronic insomnia compared with those in the population sample who slept ≥6 hours.